KYORIN Pharmaceutical Co., Ltd. - Your health is Kyorin's mission.

Top Message

Kyorin is conducting CSR activities based on its corporate philosophy that continues to fulfill its mission of cherishing life and benefiting society by contributing to better health.

News Release

March 31, 2021

KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
February 18, 2021

NHI Drug Price Listing and Release of injectable New Quinolone Antibacterial Agent "Lasvic® Intravenous Drip Infusion Kit 150mg"
January 29, 2021

Release of four research reagents for Microfluidic Real-Time PCR System GeneSoC®
January 22, 2021

Kyorin Pharmaceutical Receives Marketing Approval for the Interstitial cystitis "Zymso® Intravesical Solution 50%"
November 27, 2020

Kyorin Pharmaceutical Receives Marketing Approval for injectable New Quinolone Antibacterial Agent "Lasvic® Intravenous Drip Infusion Kit 150mg"

About our Business

Kyorin Group

KYORIN Co,.Ltd.

A holding company in charge of planning and promoting of Group-wide management strategies

KYORIN Rimedio Co., Ltd.

Generic drugs,
over-the-counter drugs and others

KYORIN Pharmaceutical Facilities Co., Ltd.

Manufacture and sales of prescription drugs